Clinical Study
Analysis of Safety from a Human Clinical Trial with Pterostilbene
Table 1
Baseline Demographics.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
āaincludes hypertension (overall incidence: 55%), diabetes (5%), atherosclerotic cardiovascular disease (1%), or restrictive/obstructive airway disease (8%). āb>75% of the cholesterol medication used in any group were statins. |